Empiesa A Vivir - CA Los Angeles, Los Angeles 90018

Empiesa A Vivir entered the industry of Substance Abuse Clinics (Outpatient) in 0 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 621498, which describes it as a Substance Abuse Clinics (Outpatient). For further clarification, the SIC classifies this business under the code 8093 and described it as a Substance Abuse Clinics (Outpatient). The business provides service to the B2C market.

To acquire more information, please contact Empiesa A Vivir by calling (847) 881-8705 during business hours. You can also write to the business’ Single Location at 2705 West Jefferson Boulevard, Los Angeles, California CA 90018. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Empiesa A Vivir
Representative: Empiesa A Vivir
Place of Business: 2705 West Jefferson Boulevard, Los Angeles, CA 90018
Contact Number: (847) 881-8705
Type of Service: Substance Abuse Clinics (Outpatient)
SIC Number: 8093
NAICS Number: 621498
Locality: Single Location
Market Type: B2C (Business to Consumer)
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Empiesa A Vivir is a company operating from Los Angeles, California providing professional Substance Abuse Clinics (Outpatient) and relevant B2C variables. It was founded in 0 and registered with the SIC code 8093 as Substance Abuse Clinics (Outpatient), and with the NAICS code 621498 as Substance Abuse Clinics (Outpatient).

With a current employee count of 1 to 4, Empiesa A Vivir has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Empiesa A Vivir at (847) 881-8705 for related queries, or to locate its Single Location using the coordinates .

The Single Location can also be found at the street address 2705 West Jefferson Boulevard in Los Angeles, California 90018 and can be engaged online through the company website at , the company Twitter , and Facebook page .